Facebook
Twitter
LinkedIn

Media Center

FAST, Fellow and CARB-X Update June 2019
Facebook
Twitter
LinkedIn

FAST & Fellows Round-Up

  • GigaGen (FAST Spring ’15) was listed as 1 of 6 award-winning life science companies in the Bay Area by BioSpace Read More
  • Whole Biome (FAST Spring ’14) secured $35M in Series B financing, led by Sequoia Capital Read More and just announced positive clinical results showing the efficacy of its proprietary microbiome Live SynbioticsTM formulation in improving glucose control in patients w/ T2D Read More

CARB-X Updates

  • CARB-X awards Oxford Drug Design funding to develop a new class of antibiotics to treat drug-resistant Gram-negative infections Read More
  • CARB-X funds Debiopharm to develop a new class of antibiotics to treat hospital-acquired pneumonia caused by multidrug-resistant superbug Acinetobacter baumannii Read More